Identification of a Recurrent STRN/ALK Fusion in Thyroid CarcinomasGaëlle Pérot, Frédéric Chibon|PLoS ONE|2014Cited by 93
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcomeMatthew L. Hemming, James E. Bradner, Ewa Sicińska et al.|Proceedings of the National Academy of Sciences|2018Cited by 43
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomasInga‐Marie Schaefer, Jonathan A. Fletcher, Meijun Z. Lundberg et al.|Cancer|2021Cited by 35
Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapyMarieke A. de Graaff, Judith V.M.G. Bovée, Jonathan A. Fletcher et al.|British Journal of Cancer|2016Cited by 19
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of LeiomyosarcomasÉlodie Darbo, Frédéric Chibon|Cancers|2023Cited by 6